CDKN2B-AS1 and hepatocellular carcinoma: Recent study demonstrated that ANRIL was increased in HCC, and inhibition of ANRIL could suppress cell proliferation, metastasis, and induce apoptosis of HepG2 and SMMC7721 cells [27].